Amendis
Amendis develops an AI-powered test to assess the risk of tumor spread in the neck, aiming to prevent unnecessary surgeries.
About
Amendis is a health tech company focused on developing innovative solutions for medical diagnostics. Their primary product is an AI-powered test designed to accurately assess the risk of tumor spread in the neck, with the goal of reducing the need for invasive and potentially unnecessary surgeries. Teams look it up for Genomics, Healthcare, Diagnostics.
Frequently asked
What does Amendis do?
Amendis is a Genomics company that offers Software. Teams look it up for Healthcare, Diagnostics, Cancer. It is based in Tel Aviv, Israel and was founded in 2008. Public records show about 55 people. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Where is Amendis headquartered?
Amendis is headquartered in Tel Aviv, Israel.
When was Amendis founded?
Amendis was founded in 2008.
What industry does Amendis operate in?
Amendis operates in Genomics, Healthcare, Diagnostics, Cancer, Metastasis.
How many employees does Amendis have?
Amendis has approximately 55 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.